Lixia Yao

Lixia Yao

Central US Merck & Co., Inc. - Kenilworth / United States
Engineering & Technology / Computer Science
AD Scientific Index ID: 4386059
-
person_outline Lixia Yao's MOST POPULAR ARTICLES
1-) Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: a model based analysisV Daniels, K Saxena, C Roberts, S Kothari, S Corman, L Yao, L NiccolaiVaccine 39 (20), 2731-2735, 20211072021
2-) Simultaneous improvement in the precision, accuracy, and robustness of label-free proteome quantification by optimizing data manipulation chainsJ Tang, J Fu, Y Wang, Y Luo, Q Yang, B Li, G Tu, J Hong, X Cui, Y Chen, ...Molecular & Cellular Proteomics 18 (8), 1683-1699, 20191072019
3-) Quantitative systems-level determinants of human genes targeted by successful drugsL Yao, A RzhetskyGenome Research 18 (2), 206-213, 2008962008
4-) Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: a database analysisSA Kujawski, L Yao, HE Wang, C Carias, YT ChenVaccine 40 (5), 706-713, 2022772022
5-) Electronic health records: Implications for drug discoveryL Yao, Y Zhang, Y Li, P Sanseau, P AgarwalDrug discovery today 16 (13-14), 594-599, 2011672011